المؤلفون: Curigliano G., Mueller V., Borges V., Hamilton E., Hurvitz S., Loi S., Murthy R., Okines A., Paplomata E., Cameron D., Carey L. A., Gelmon K., Hortobagyi G. N., Krop I., Loibl S., Pegram M., Slamon D., Ramos J., Feng W., Winer E.

المساهمون: G. Curigliano, V. Mueller, V. Borge, E. Hamilton, S. Hurvitz, S. Loi, R. Murthy, A. Okine, E. Paplomata, D. Cameron, L.A. Carey, K. Gelmon, G.N. Hortobagyi, I. Krop, S. Loibl, M. Pegram, D. Slamon, J. Ramo, W. Feng, E. Winer

مصطلحات موضوعية: brain metastase, capecitabine, human epidermal growth factor receptor 2-positive (HER2), metastatic breast cancer, trastuzumab, tucatinib, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34954044; info:eu-repo/semantics/altIdentifier/wos/WOS:000755659500011; volume:33; issue:3; firstpage:321; lastpage:329; numberofpages:9; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/910202Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123294615

الإتاحة: https://doi.org/10.1016/j.annonc.2021.12.005Test
http://hdl.handle.net/2434/910202Test

المؤلفون: Curigliano, G, Mueller, V, Borges, V, Hamilton, E, Hurvitz, S, Loi, S, Murthy, R, Okines, A, Paplomata, E, Cameron, D, Carey, LA, Gelmon, K, Hortobagyi, GN, Krop, I, Loibl, S, Pegram, M, Slamon, D, Ramos, J, Feng, W, Winer, E

العلاقة: pii: S0923-7534(21)04879-1; Curigliano, G., Mueller, V., Borges, V., Hamilton, E., Hurvitz, S., Loi, S., Murthy, R., Okines, A., Paplomata, E., Cameron, D., Carey, L. A., Gelmon, K., Hortobagyi, G. N., Krop, I., Loibl, S., Pegram, M., Slamon, D., Ramos, J., Feng, W. & Winer, E. (2022). Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis. Ann Oncol, 33 (3), pp.321-329. https://doi.org/10.1016/j.annonc.2021.12.005Test.; http://hdl.handle.net/11343/308715Test

الإتاحة: https://doi.org/10.1016/j.annonc.2021.12.005Test
http://hdl.handle.net/11343/308715Test

المؤلفون: Gennari, A., Andre, F., Barrios, C. H., Cortes, J., de Azambuja, E., DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S. A., Im, S. -a., Krug, D., Kunz, W. G., Loi, S., Penault-Llorca, F., Ricke, J., Robson, M., Rugo, H. S., Saura, C., Schmid, P., Singer, C. F., Spanic, T., Tolaney, S. M., Turner, N. C., Curigliano, G., Loibl, S., Paluch-Shimon, S., Harbeck, N., ESMO Guidelines Committee

المساهمون: 임석아, Im, S. -a.

مصطلحات موضوعية: INTERNATIONAL CONSENSUS GUIDELINES, ALPELISIB PLUS FULVESTRANT, GERMLINE BRCA MUTATION, DOUBLE-BLIND, OPEN-LABEL, PHYSICIANS CHOICE, SACITUZUMAB GOVITECAN, TRASTUZUMAB EMTANSINE, REPORTED OUTCOMES, ENDOCRINE THERAPY, diagnosis, ESCAT, ESMO Clinical Practice Guideline, ESMO-MCBS, metastatic breast cancer, treatment

العلاقة: Annals of Oncology, Vol.32 No.12, pp.1475-1495; 153495; https://hdl.handle.net/10371/179242Test; 000721610600008; 2-s2.0-85120812833

الإتاحة: https://doi.org/10.1016/j.annonc.2021.09.019Test
https://hdl.handle.net/10371/179242Test

المؤلفون: Onesti C. E., Rugo H. S., Generali D., Peeters M., Zaman K., Wildiers H., Harbeck N., Martin M., Cristofanilli M., Cortes J., Tjan-Heijnen V., Hurvitz S. A., Berchem G., Tagliamento M., Campone M., Bartsch R., De Placido S., Puglisi F., Rottey S., Muller V., Ruhstaller T., MacHiels J. -P., Conte P., Awada A., Jerusalem G.

المساهمون: Onesti, C. E., Rugo, H. S., Generali, D., Peeters, M., Zaman, K., Wildiers, H., Harbeck, N., Martin, M., Cristofanilli, M., Cortes, J., Tjan-Heijnen, V., Hurvitz, S. A., Berchem, G., Tagliamento, M., Campone, M., Bartsch, R., De Placido, S., Puglisi, F., Rottey, S., Muller, V., Ruhstaller, T., Machiels, J. -P., Conte, P., Awada, A., Jerusalem, G.

مصطلحات موضوعية: COVID-19, oncological care, Betacoronaviru, Cancer Care Facilitie, Coronavirus Infection, Delivery of Health Care, Disinfection, Europe, Health Care Survey, Human, Medical Oncology, Neoplasm, Pandemic, Personal Protective Equipment, Pneumonia, Viral, SARS-CoV-2, Triage, United State, Visitors to Patients

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32847836; info:eu-repo/semantics/altIdentifier/wos/WOS:000567378100006; volume:5; issue:4; firstpage:"-"; lastpage:"-"; numberofpages:8; journal:ESMO OPEN; http://hdl.handle.net/11368/2993105Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85089988945; https://www.sciencedirect.com/science/article/pii/S2059702920326648?via=ihubTest#!; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451457Test/

الإتاحة: https://doi.org/10.1136/esmoopen-2020-000853Test
http://hdl.handle.net/11368/2993105Test
https://www.sciencedirect.com/science/article/pii/S2059702920326648?via=ihubTest#!
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451457Test/

المؤلفون: Curigliano, G., Murthy, R., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Cameron, D., Borges, V., Bedard, P., Oliveira, M., Jakobsen, E. H., Bachelot, T., Shachar, S. S., Mueller, V., Carey, L. A., Loibl, S., Feng, W., Walker, L. N., Winer, E.

المصدر: Curigliano , G , Murthy , R , Loi , S , Okines , A , Paplomata , E , Hamilton , E , Hurvitz , S A , Cameron , D , Borges , V , Bedard , P , Oliveira , M , Jakobsen , E H , Bachelot , T , Shachar , S S , Mueller , V , Carey , L A , Loibl , S , Feng , W , Walker , L N & Winer , E 2020 , ' Tucatinib vs placebo added to trastuzumab and capecitabine in previously treated HER2+metastatic ....

الإتاحة: https://doi.org/10.1016/j.annonc.2020.03.238Test
https://portal.findresearcher.sdu.dk/da/publications/1fc3a435-2a58-47ea-a381-00e2d80af4a7Test

المؤلفون: Gennari A., Andre F., Barrios C. H., Cortes J., de Azambuja E., DeMichele A., Dent R., Fenlon D., Gligorov J., Hurvitz S. A., Im S. -A., Krug D., Kunz W. G., Loi S., Penault-Llorca F., Ricke J., Robson M., Rugo H. S., Saura C., Schmid P., Singer C. F., Spanic T., Tolaney S. M., Turner N. C., Curigliano G., Loibl S., Paluch-Shimon S., Harbeck N.

المساهمون: A. Gennari, F. Andre, C.H. Barrio, J. Corte, E. de Azambuja, A. Demichele, R. Dent, D. Fenlon, J. Gligorov, S.A. Hurvitz, S.-. Im, D. Krug, W.G. Kunz, S. Loi, F. Penault-Llorca, J. Ricke, M. Robson, H.S. Rugo, C. Saura, P. Schmid, C.F. Singer, T. Spanic, S.M. Tolaney, N.C. Turner, G. Curigliano, S. Loibl, S. Paluch-Shimon, N. Harbeck

مصطلحات موضوعية: diagnosi, ESCAT, ESMO Clinical Practice Guideline, ESMO-MCBS, metastatic breast cancer, treatment, Female, Human, Medical Oncology, Breast Neoplasms, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34678411; info:eu-repo/semantics/altIdentifier/wos/WOS:000721610600008; volume:32; issue:12; firstpage:1475; lastpage:1495; numberofpages:21; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2434/910168Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120812833

الإتاحة: https://doi.org/10.1016/j.annonc.2021.09.019Test
http://hdl.handle.net/2434/910168Test

المؤلفون: Hurvitz S. A., Hegg R., Chung W. -P., Im S. -A., Jacot W., Ganju V., Chiu J. W. Y., Xu B., Hamilton E., Madhusudan S., Iwata H., Altintas S., Henning J. -W., Curigliano G., Perez-Garcia J. M., Kim S. -B., Petry V., Huang C. -S., Li W., Frenel J. -S., Antolin S., Yeo W., Bianchini G., Loi S., Tsurutani J., Egorov A., Liu Y., Cathcart J., Ashfaque S., Cortes J.

المساهمون: Hurvitz, S. A., Hegg, R., Chung, W. -P., Im, S. -A., Jacot, W., Ganju, V., Chiu, J. W. Y., Xu, B., Hamilton, E., Madhusudan, S., Iwata, H., Altintas, S., Henning, J. -W., Curigliano, G., Perez-Garcia, J. M., Kim, S. -B., Petry, V., Huang, C. -S., Li, W., Frenel, J. -S., Antolin, S., Yeo, W., Bianchini, G., Loi, S., Tsurutani, J., Egorov, A., Liu, Y., Cathcart, J., Ashfaque, S., Cortes, J.

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000924006800001; volume:401; issue:10371; firstpage:105; lastpage:117; numberofpages:13; journal:THE LANCET; https://hdl.handle.net/20.500.11768/161736Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85143885860

الإتاحة: https://doi.org/20.500.11768/16173610.1016/S0140-6736Test(22)02420-5
https://hdl.handle.net/20.500.11768/161736Test

المؤلفون: Lin N. U., Borges V., Anders C., Murthy R. K., Paplomata E., Hamilton E., Hurvitz S., Loi S., Okines A., Abramson V., Bedard P. L., Oliveira M., Mueller V., Zelnak A., DiGiovanna M. P., Bachelot T., Jo Chien A., O'Regan R., Wardley A., Conlin A., Cameron D., Carey L., Curigliano G., Gelmon K., Loibl S., Mayor J., McGoldrick S., An X., Winer E. P.

المساهمون: N.U. Lin, V. Borge, C. Ander, R.K. Murthy, E. Paplomata, E. Hamilton, S. Hurvitz, S. Loi, A. Okine, V. Abramson, P.L. Bedard, M. Oliveira, V. Mueller, A. Zelnak, M.P. Digiovanna, T. Bachelot, A. Jo Chien, R. O'Regan, A. Wardley, A. Conlin, D. Cameron, L. Carey, G. Curigliano, K. Gelmon, S. Loibl, J. Mayor, S. Mcgoldrick, X. An, E.P. Winer

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, Brain Neoplasm, Breast Neoplasm, Capecitabine, Disease Progression, Double-Blind Method, Female, Human, Middle Aged, Oxazole, Pyridine, Quinazoline, Receptor, ErbB-2, Trastuzumab, Young Adult, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32468955; info:eu-repo/semantics/altIdentifier/wos/WOS:000559991300004; volume:38; issue:23; firstpage:2610; lastpage:2619; numberofpages:10; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/2434/824756Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85086111080

الإتاحة: https://doi.org/10.1200/JCO.20.00775Test
http://hdl.handle.net/2434/824756Test

المؤلفون: Lin, N, Murthy, R, Anders, C, Borges, V, Hurvitz, S, Loi, S, Abramson, V, Bedard, P, Oliveira, M, Zelnack, A, DiGiovanna, M, Bachelot, T, Chien, AJ, O’Regan, R, Wardley, A, Mueller, V, Carey, L, McGoldrick, S, An, X, Winer, E

العلاقة: Lin, N., Murthy, R., Anders, C., Borges, V., Hurvitz, S., Loi, S., Abramson, V., Bedard, P., Oliveira, M., Zelnack, A., DiGiovanna, M., Bachelot, T., Chien, A. J., O’Regan, R., Wardley, A., Mueller, V., Carey, L., McGoldrick, S., An, X. & Winer, E. (2020). 53. TUCATINIB VS PLACEBO ADDED TO TRASTUZUMAB AND CAPECITABINE FOR PATIENTS WITH PREVIOUSLY TREATED HER2+ METASTATIC BREAST CANCER (MBC) WITH BRAIN METASTASES (BM) (HER2CLIMB). [Abstract]. Neuro-Oncology Advances, 2 (Supplement_2), pp.ii11-ii11. https://doi.org/10.1093/noajnl/vdaa073.041Test.; http://hdl.handle.net/11343/273862Test

الإتاحة: https://doi.org/10.1093/noajnl/vdaa073.041Test
http://hdl.handle.net/11343/273862Test

المؤلفون: Lin, NU, Borges, V, Anders, C, Murthy, RK, Paplomata, E, Hamilton, E, Hurvitz, S, Loi, S, Okines, A, Abramson, V, Bedard, PL, Oliveira, M, Mueller, V, Zelnak, A, DiGiovanna, MP, Bachelot, T, Chien, AJ, O'Regan, R, Wardley, A, Conlin, A, Cameron, D, Carey, L, Curigliano, G, Gelmon, K, Loibl, S, Mayor, J, McGoldrick, S, An, X, Winer, EP

العلاقة: Lin, N. U., Borges, V., Anders, C., Murthy, R. K., Paplomata, E., Hamilton, E., Hurvitz, S., Loi, S., Okines, A., Abramson, V., Bedard, P. L., Oliveira, M., Mueller, V., Zelnak, A., DiGiovanna, M. P., Bachelot, T., Chien, A. J., O'Regan, R., Wardley, A. ,. Winer, E. P. (2020). Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial. JOURNAL OF CLINICAL ONCOLOGY, 38 (23), pp.2610-+. https://doi.org/10.1200/JCO.20.00775Test.; http://hdl.handle.net/11343/287098Test

الإتاحة: https://doi.org/10.1200/JCO.20.00775Test
http://hdl.handle.net/11343/287098Test